Rallybio CorporationRLYBNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-19.2%
5Y CAGR+13.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-19.2%/yr
Annual compound
5Y CAGR
+13.3%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$14.32M-27.0%
2024$19.63M-22.7%
2023$25.39M-6.6%
2022$27.20M+45.1%
2021$18.74M+144.2%
2020$7.67M+22.3%
2019$6.28M-